Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New lifestyle program aims to boost quality of life for prostate cancer patients

NCT ID NCT03575832

Symptom relief Sponsor: M.D. Anderson Cancer Center Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Aug 12, 2026 · Updated 2 times

Summary

This pilot study tests a lifestyle intervention called Watchful Living for Black and Hispanic prostate cancer patients on active surveillance and their partners. The program includes nutrition counseling, an exercise plan, and telephone coaching to improve quality of life, physical activity, and diet. The study enrolls 64 participants and focuses on whether the program is feasible and acceptable.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
lifestyle intervention (nutrition counseling, exercise plan, telephone coaching)
What this could lead to
If it works, this could point toward a simple, supportive program that helps prostate cancer patients and their partners feel better and live healthier.
What could go wrong
This is a very small pilot study with only 64 participants, so results may not apply to everyone. It focuses on feasibility, not on curing cancer.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

64 people

The number who actually took part.

Started

Jan 2018

Expected to finish

Dec 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Self-identify as black or African American or Hispanic (patient) * Be greater than 18 years of age (patient and spouse or intimate partner) * Have 0-III stage prostate cancer (patient) * If treated, have completed therapy (e.g., surgery, chemo and/or radiation) (patient) * Enroll with a spouse or intimate partner (patient) * Do not meet physical activity recommendation (i.e., 150 minutes of moderate intensity physical activity per week) (patient and spouse or intimate partner) * Be ready and able to be physically active, as determined by a physician (letter from a physician or nurse practitioner) (patient and spouse or intimate partner) * Not participate in another physical activity, diet, or lifestyle program (patient) * Have a valid home address and telephone number (patient) * Internet access at home or other location (e.g., work, church, library, community center, etc.) (spouse or intimate partner) * Patients on active surveillance will be included Exclusion Criteria: * They have an active noncutaneous malignancy at any site (patient) * Had prior radiation therapy for treatment of the primary tumor (patient) * Have planned concomitant immunotherapy, hormonal therapy, chemotherapy, or radiation therapy during the study period (patient) * Are enrolled in another active surveillance protocol (patient) * Participated in formative focus groups for this study (patient and spouse or intimate partner)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Stage I prostate cancer ajcc V8 are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

prostate cancer prostate carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Stage I prostate cancer ajcc V8 Stage II prostate cancer ajcc V8 Stage IIA prostate cancer ajcc V8 Stage IIB prostate cancer ajcc V8 Stage IIC prostate cancer ajcc V8 Stage III prostate cancer ajcc V8 Stage IIIA prostate cancer ajcc V8 Stage IIIB prostate cancer ajcc V8 Stage IIIC prostate cancer ajcc V8

Contacts and locations

Locations

  • Harris Health System (LBJ)

    Houston, Texas, 77026, United States

  • M D Anderson Cancer Center

    Houston, Texas, 77030, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.